1. Home
  2. KYMR vs CWK Comparison

KYMR vs CWK Comparison

Compare KYMR & CWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KYMR
  • CWK
  • Stock Information
  • Founded
  • KYMR 2015
  • CWK 1784
  • Country
  • KYMR United States
  • CWK United States
  • Employees
  • KYMR N/A
  • CWK N/A
  • Industry
  • KYMR Medicinal Chemicals and Botanical Products
  • CWK Real Estate
  • Sector
  • KYMR Health Care
  • CWK Finance
  • Exchange
  • KYMR Nasdaq
  • CWK Nasdaq
  • Market Cap
  • KYMR 1.8B
  • CWK 1.9B
  • IPO Year
  • KYMR 2020
  • CWK 2018
  • Fundamental
  • Price
  • KYMR $45.87
  • CWK $10.48
  • Analyst Decision
  • KYMR Strong Buy
  • CWK Hold
  • Analyst Count
  • KYMR 16
  • CWK 7
  • Target Price
  • KYMR $59.38
  • CWK $13.00
  • AVG Volume (30 Days)
  • KYMR 1.1M
  • CWK 1.5M
  • Earning Date
  • KYMR 08-06-2025
  • CWK 07-28-2025
  • Dividend Yield
  • KYMR N/A
  • CWK N/A
  • EPS Growth
  • KYMR N/A
  • CWK 1337.16
  • EPS
  • KYMR N/A
  • CWK 0.69
  • Revenue
  • KYMR $58,885,000.00
  • CWK $9,546,300,000.00
  • Revenue This Year
  • KYMR $43.38
  • CWK $5.77
  • Revenue Next Year
  • KYMR $10.97
  • CWK $5.65
  • P/E Ratio
  • KYMR N/A
  • CWK $15.20
  • Revenue Growth
  • KYMR N/A
  • CWK 1.24
  • 52 Week Low
  • KYMR $19.45
  • CWK $7.64
  • 52 Week High
  • KYMR $53.27
  • CWK $16.11
  • Technical
  • Relative Strength Index (RSI)
  • KYMR 67.58
  • CWK 54.57
  • Support Level
  • KYMR $45.80
  • CWK $10.14
  • Resistance Level
  • KYMR $47.51
  • CWK $10.71
  • Average True Range (ATR)
  • KYMR 2.86
  • CWK 0.30
  • MACD
  • KYMR -0.03
  • CWK -0.01
  • Stochastic Oscillator
  • KYMR 67.19
  • CWK 59.70

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

About CWK Cushman & Wakefield plc

Cushman & Wakefield is one of the largest commercial real estate services firms in the world, with global headquarters in Chicago. The firm provides various real estate-related services to owners, occupiers, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such valuation, project management, and facilities management.

Share on Social Networks: